Fusion Pharmaceuticals Inc. Lease, Cost
Fusion Pharmaceuticals Inc. reported Lease, Cost of $1.23 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. lease, cost for the quarter ending 2024-03-31 was $1.23M, a 138.22% increase year-over-year.
- Fusion Pharmaceuticals Inc. lease, cost for the quarter ending 2023-12-31 was $1.24M, a 222.98% increase year-over-year.
- Fusion Pharmaceuticals Inc. lease, cost for the quarter ending 2023-09-30 was $1.01M, a 162.02% increase year-over-year.
- Fusion Pharmaceuticals Inc. lease, cost for the quarter ending 2023-06-30 was $1.12M, a 183.08% increase year-over-year.
- Fusion Pharmaceuticals Inc. lease, cost for fiscal 2023 was $3.89M, a 151.78% increase from fiscal 2022.
- Fusion Pharmaceuticals Inc. lease, cost for fiscal 2022 was $1.54M, a 8.96% increase from fiscal 2021.
- Fusion Pharmaceuticals Inc. lease, cost for fiscal 2021 was $1.42M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.23M 10-Q · filed 2024-05-07 | $2.47M derived: sum of 2 quarters · filed 2024-05-07 | $3.48M derived: sum of 3 quarters · filed 2024-05-07 | $4.61M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $2.25M derived: sum of 2 quarters · filed 2024-03-20 | $3.37M derived: sum of 3 quarters · filed 2024-03-20 | $3.89M 10-K · filed 2024-03-20 |
| 2023-09-30 | $1.01M 10-Q · filed 2023-11-07 | $2.13M derived: sum of 2 quarters · filed 2023-11-07 | $2.65M 10-Q · filed 2023-11-07 | $3.04M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $1.12M 10-Q · filed 2023-08-08 | $1.64M 10-Q · filed 2023-08-08 | $2.02M derived: sum of 3 quarters · filed 2024-05-07 | $2.41M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $518.00K 10-Q · filed 2024-05-07 | $901.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.29M derived: sum of 3 quarters · filed 2024-05-07 | $1.68M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $770.00K derived: sum of 2 quarters · filed 2024-03-20 | $1.17M derived: sum of 3 quarters · filed 2024-03-20 | $1.54M 10-K · filed 2024-03-20 |
| 2022-09-30 | $387.00K 10-Q · filed 2023-11-07 | $783.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.16M 10-Q · filed 2023-11-07 | $1.53M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $396.00K 10-Q · filed 2023-08-08 | $775.00K 10-Q · filed 2023-08-08 | $1.14M derived: sum of 3 quarters · filed 2023-08-08 | $1.51M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $379.00K 10-Q · filed 2023-05-11 | $745.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.11M derived: sum of 3 quarters · filed 2023-05-11 | $1.50M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $735.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.12M derived: sum of 3 quarters · filed 2023-03-16 | $1.42M 10-K · filed 2023-03-16 |
| 2021-09-30 | $369.00K 10-Q · filed 2022-11-08 | $752.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.05M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $383.00K 10-Q · filed 2022-08-09 | $683.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-10 |